Arrowhead Pharmaceuticals

$46.66

-$0.30 (-0.64%) As of 4:46 PM UTC today
1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARWR and other ETFs, options, and stocks.

About ARWR

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. 

CEO
Christopher Richard Anzalone
CEOChristopher Richard Anzalone
Employees
329
Employees329
Headquarters
Pasadena, California
HeadquartersPasadena, California
Founded
1989
Founded1989
Employees
329
Employees329

ARWR Key Statistics

Market cap
4.93B
Market cap4.93B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
813.16K
Average volume813.16K
High today
$48.08
High today$48.08
Low today
$45.97
Low today$45.97
Open price
$46.96
Open price$46.96
Volume
188.71K
Volume188.71K
52 Week high
$84.83
52 Week high$84.83
52 Week low
$26.81
52 Week low$26.81

Analyst ratings

90%

of 10 ratings
Buy
90%
Hold
10%
Sell
0%

ARWR Earnings

-$0.68
-$0.32
$0.05
$0.41
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
-$0.51 per share
Estimated-$0.51 per share
Actual
-$0.68 per share
Actual-$0.68 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.